임상시험 트래커

추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov

31건 표시

1/2상모집 예정· High-Grade Glioma (HGG)
A Safety and Efficacy Study of Combined Fianlimab + Cemiplimab in Children and Young Adults With Recurrent or Progressive High-Grade Glioma or Posterior Fossa-A Ependymoma
리드: 리제네론
상세 →NCT07567469
1/2상모집 예정· Ovarian Cancer
Safety and Efficacy of Ubamatamab With First-line Chemotherapy in Ovarian Cancer
협력: 리제네론
상세 →NCT07637851
1/2상모집 예정· Primary Open Angle Glaucoma (POAG)
REGN22530 for Adults With Primary Open Angle Glaucoma or Ocular Hypertension
리드: 리제네론
상세 →NCT07675824
1/2상모집 중· Rheumatoid Arthritis
Phase 1b/2 Study of IV Sarilumab in Adult With RA
리드: 사노피 · 협력: 리제네론
상세 →NCT07704580
1/2상모집 예정· Metastatic Castration-Resistant Prostate Cancer (mCRPC)
REGN15505 (PSMAx4-1BB) Alone or in Combination With Cemiplimab or REGN4336 (PSMAxCD3) in Adult Patients With Metastatic Castration-Resistant Prostate Cancer and Clear Cell Renal Cell Carcinoma
리드: 리제네론
상세 →NCT07594106
1/2상모집 중· Relapsed Refractory Multiple Myeloma (RRMM)
A Trial to Study if REGN17372 in Combination With Linvoseltamab is Tolerable for Adult Participants With Relapsed/Refractory Multiple Myeloma
리드: 리제네론
상세 →NCT07455851
1/2상모집 중· Recurrent Multiple Myeloma
Response-Based Dose Reduction of Linvoseltamab in the Treatment of Relapsed, Refractory, or Triple-Class Relapsed/Refractory Multiple Myeloma
협력: 리제네론
상세 →NCT07181941
1/2상모집 중· Paroxysmal Nocturnal Hemoglobinuria (PNH)
A First-in-Human Safety and Efficacy Study of ALN-CFB, a Small Interfering RNA (siRNA) Targeting Complement Factor B, in Adult Participants With Paroxysmal Nocturnal Hemoglobinuria With Persistent Anemia on a C5 Inhibitor
리드: 리제네론
상세 →NCT07187401
1/2상모집 중단 (진행 중)· Active Noninfectious Uveitis Affecting the Posterior Segment
A Study of REGN7041 for Active Noninfectious Uveitis in Adult Participants
리드: 리제네론
상세 →NCT07218770
1/2상모집 중· Cutaneous Basal Cell Carcinoma
Cemiplimab Plus Imiquimod and Laser Therapy As Neoadjuvant Treatment In Cutaneous Basal Cell Carcinoma
협력: 리제네론
상세 →NCT07251413
1/2상모집 중· Metabolic Dysfunction-Associated Steatotic Liver Disease
A Study to Evaluate ALN-CIDEB in Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease or With Metabolic Dysfunction-Associated Steatohepatitis (MASLD/MASH)
리드: 리제네론
상세 →NCT06836609
1/2상모집 중· Relapsed/Refractory Multiple Myeloma
A Study to Assess the Safety and Anti-Tumor Activity of REGN7945 in Combination With Linvoseltamab in Adult Participants With Relapsed/Refractory Multiple Myeloma
리드: 리제네론
상세 →NCT06669247
1/2상모집 중· Melanoma
A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body
리드: 리제네론
상세 →NCT06413680
1/2상모집 중· Hemophilia B
A Study to Investigate the Safety and Effectiveness of a Coagulation Factor IX Gene Insertion Therapy (REGV131-LNP1265) in Pediatric, Adolescent and Adult Participants With Hemophilia B
리드: 리제네론
상세 →NCT06379789
1/2상모집 중· Amyotrophic Lateral Sclerosis (ALS)
First in Human (FIH) Study of ALN-SOD in Adult Participants With Amyotrophic Lateral Sclerosis Associated With Mutation in the SOD1 Gene (SOD1-ALS)
리드: 리제네론
상세 →NCT06351592
1/2상모집 중· Relapsed/Refractory Systemic Light Chain Amyloidosis
A Trial to Learn if Linvoseltamab is Safe and Works in Adults With Relapsed or Refractory Systemic Light Chain Amyloidosis (AL Amyloidosis)
리드: 리제네론
상세 →NCT06292780
1/2상모집 중단 (진행 중)· Non-small Cell Lung Cancer (NSCLC)
Phase 1b/2 Platform Study of Select Immunotherapy Combinations in Participants With Advanced Non-small Cell Lung Cancer (NSCLC)
협력: 리제네론
상세 →NCT06162572
1/2상모집 중· Multiple Myeloma
A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerated, and How Well it Works in Adult Participants With Recently Diagnosed Multiple Myeloma Who Have Not Already Received Treatment
리드: 리제네론
상세 →NCT05828511
1/2상모집 중· Congenital Hearing Loss Secondary to Biallelic Mutations of the Otoferlin Gene (OTOF)
A Study of DB-OTO, an Adeno-Associated Virus (AAV) Based Gene Therapy, in Children/Infants, Adolescents and Adults With Hearing Loss Due to Otoferlin Mutations
리드: 리제네론
상세 →NCT05788536
1/2상모집 중단 (진행 중)· Solid Tumor, Adult
A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors
협력: 리제네론
상세 →NCT05864144
1/2상모집 중· Healthy Volunteers
A Trial to Learn if ALN-PNP is Safe and Well Tolerated in Healthy Adults and Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
리드: 리제네론
상세 →NCT05648214
1/2상모집 중단 (진행 중)· Chronic Kidney Disease (CKD)
A Study to Learn How Safe and Tolerable Vonsetamig is in Adult Patients With Chronic Kidney Disease (CKD) Who Need Kidney Transplantation and Are Highly Sensitized to Human Leukocyte Antigen (HLA)
리드: 리제네론
상세 →NCT05092347
1/2상모집 중단 (진행 중)· Metastatic Solid Tumor
LAG3 PET Imaging in Advanced Solid Tumors
협력: 리제네론
상세 →NCT04706715
1/2상모집 중단 (진행 중)· Prostate Cancer
Androgen Deprivation, With or Without pTVG-AR, and With or Without T-Cell Checkpoint Blockade, in Patients With Newly Diagnosed, High-Risk Prostate Cancer
협력: BMS, 리제네론
상세 →NCT04989946
1/2상모집 중· Metastatic Castration-resistant Prostate Cancer
A Trial to Find Out if REGN4336 is Safe and How Well it Works Alone and in Combination With REGN5678 for Adult Participants With Advanced Prostate Cancer
리드: 리제네론
상세 →NCT05125016
1/2상모집 중단 (진행 중)· Advanced Solid Tumors
A Trial to Find Out How Safe REGN7075 is and How Well it Works in Combination With Cemiplimab for Adult Participants With Advanced Cancers
리드: 리제네론
상세 →NCT04626635
1/2상모집 중· Ovarian Cancer
A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab
리드: 리제네론
상세 →NCT04590326
1/2상모집 중· NSCLC
A Study of REGN5093 in Adult Patients With Mesenchymal Epithelial Transition Factor (MET)-Altered Advanced Non-Small Cell Lung Cancer
리드: 리제네론
상세 →NCT04077099
1/2상모집 중· Metastatic Castration-Resistant Prostate Cancer (mCRPC)
A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors
리드: 리제네론
상세 →NCT03972657
1/2상모집 중· Multiple Myeloma
Phase 1/2 Study of Linvoseltamab in Adult Patients With Relapsed or Refractory Multiple Myeloma
리드: 리제네론
상세 →NCT03761108
1/2상모집 중· Recurrent Ovarian Cancer
Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers
리드: 리제네론
상세 →NCT03564340

BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.